Targeting these receptors preclinically can mitigate pathogenic β-amyloid and tau neurotoxicity whilst

Targeting these receptors preclinically can mitigate pathogenic β-amyloid and tau neurotoxicity whilst

carboxypeptidase E, CPE) and human 5-HTR1E, a G protein-coupled serotonin receptor with no previously known neurological diminished the NF-α1/CPE-mediated protection of these neurons against oxidative stress and glutamate neurotoxicity-induced

molecular regulation between neuropeptide and neurotransmitter release GPCRs in Oncology and Immunology Neurotoxicity

molecule drugs known as allosteric modulators is being explored for treating central nervous system and neurologic

of ligands for CB1 receptors have been developed as promising drug candidates for the treatment of neurological

fundamental physiological functions, and dysregulation of dopaminergic transmission is associated with major neurological

The CCL2/CCR2 pathway plays an important role in oncology, inflammatory, metabolic, and neurological

by suppressing the MMP8-mediated antitumorigenic effects GPR56: A potential therapeutic target for neurological kisspeptin receptor Industry News Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological

company driven to create and deliver transformative medicines for people living with psychiatric and neurological

Therefore, mGluR2 and mGluR3 have been considered as potential drug targets for the treatment of many neurological

S1R has been implicated in many neurological disorders such as anxiety, schizophrenia, and depression

serotonin1A receptor is a crucial neurotransmitter receptor in the GPCR family involved in a multitude of neurological

Adhesion GPCRs playing essential roles in the mammalian nervous system and are associated with severe neurological

and exclusively expressed in the brain, suggesting that Adgra1 may be involved in the regulation of neurological

drug discovery Is the pharma community looking hard enough before trying to engage highly challenging neurology Neuroscience GPCR-Mediated Natural Products and Compounds: Potential Therapeutic Targets for the Treatment of Neurological

Duke Novo Nordisk stops Ozempic kidney trial after early signs of success Sosei and PharmEnable extend neurological

Development and Commercialization of Voyager’s GBA1 Program and Other Next-Generation Gene Therapies for Neurological

plant Cannabis sativa, has displayed beneficial pharmacological effects in the treatment of several neurological

immunity Industry News Neurosterix launches with $63M to Advance Allosteric Modulator Therapeutics for Neurological

behavior Methods & Updates in GPCR Research Advancements in the use of xenopus oocytes for modelling neurological

Exscientia Business Update for Third Quarter 2023 Addex CEO Tim Dyer to Discuss Allosteric Modulators in Neurological

Triazolo[1,5-c]pyrimidines as Tools to Investigate A3 Adenosine Receptors in Cancer Cell Lines Severity of neurological

pain perception and reward, the dysfunction in the MOR-SNARE complex interaction can lead to various neurological

through β1 adrenergic receptor GPCRs in Neuroscience Discovery of potential TAAR1 agonist targeting neurological

development Chemokine CXCL13-CXCR5 signaling in neuroinflammation and pathogenesis of chronic pain and neurological

setpoint in Drosophila Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived Neurotropic